Join

Compare · DXCM vs IART

DXCM vs IART

Side-by-side comparison of DexCom Inc. (DXCM) and Integra LifeSciences Holdings Corporation (IART): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DXCM and IART operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • DXCM is the larger of the two at $28.11B, about 21.3x IART ($1.32B).
  • Over the past year, DXCM is down 9.4% and IART is up 23.4% - IART leads by 32.8 points.
  • DXCM has been more active in the news (26 items in the past 4 weeks vs 7 for IART).
  • DXCM has more recent analyst coverage (25 ratings vs 24 for IART).
PerformanceDXCM-9.43%IART+23.38%
2025-06-09+0.00%2026-06-08
MetricDXCMIART
Company
DexCom Inc.
Integra LifeSciences Holdings Corporation
Price
$77.56+6.47%
$17.15+0.94%
Market cap
$28.11B
$1.32B
1M return
+27.29%
+26.52%
1Y return
-9.43%
+23.38%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2005
News (4w)
26
7
Recent ratings
25
24
DXCM

DexCom Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

IART

Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Latest DXCM

Latest IART